Linden is the CEO and founder of SOLVE, an Imperial spin-out focusing on enabling the optimal selection of reaction conditions in the production of pharmaceuticals, agrochemicals, and speciality chemicals. Linden completed his PhD at Imperial College London with Prof Mimi Hii and Prof Klaus Hellgardt developing transient flow methodology to efficiently collect data from chemical reactions for which he received a departmental prize both for his thesis and final year presentation. During this time Linden engaged in many academic and industrial collaborations, most notably with BASF, produced multiple peer reviewed papers, a patent, and successfully raised £780,000 to found SOLVE.